| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 18 |
| 1 | LAMIVUDINE ORAL | 18 |
| 2 | NEVIRAPINE | 11 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE | 10 |
| 4 | ZIDOVUDINE | 9 |
| 5 | EFAVIRENZ | 8 |
| 6 | RITONAVIR | 7 |
| 7 | ABACAVIR SULFATE | 6 |
| 8 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 6 |
| 9 | LOPINAVIR AND RITONAVIR | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CYCLOSERINE | 4 | 0.0017 |
| 1 | DORAVIRINE | 1 | 0.0013 |
| 2 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| 3 | NEVIRAPINE | 11 | 0.0012 |
| 4 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 5 | ETHAMBUTOL HYDROCHLORIDE | 3 | 0.0011 |
| 6 | ZIDOVUDINE | 9 | 0.0009 |
| 7 | PYRIMETHAMINE | 1 | 0.0008 |
| 8 | EFAVIRENZ | 8 | 0.0007 |
| 9 | LAMIVUDINE | 18 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 17 | 0.0007 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 20 | 0.0004 |
| 3 | Antimycobacterial [EPC] | 7 | 0.0003 |
| 4 | Protease Inhibitor [EPC] | 12 | 0.0003 |
| 5 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 26 | 0.0002 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 12 | 0.0002 |
| 8 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 9 | Aminoglycoside Antibacterial [EPC] | 5 | 0.0001 |